Randomised, double-blind, cross-over trial of GTR (generic glatiramer acetate) in healthy volunteers shows similar tolerability and safety to Copaxone®

被引：0
|
作者：
Oberye, J. [1 ]
van den Tweel, E. [1 ]
Mulder, M. [1 ]
Voortman, G. [1 ]
Hooftman, L. [1 ]
机构：
[1] Synthon BV, Nijmegen, Netherlands
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [31] Diet Restriction in Migraine, Based on IgG Against Foods: A Clinical Double-Blind, Randomised, Cross-Over Trial
    Gokani, T.
    HEADACHE, 2012, 52 (06): : 1056 - 1057
  • [32] Pregabalin versus gabapentin in the treatment of sciatica: study protocol for a randomised, double-blind, cross-over trial (PAGPROS)
    Kelvin Robertson
    Laurence A. G. Marshman
    Maria Hennessy
    Linton Harriss
    David Plummer
    Trials, 19
  • [33] Cardiovascular safety of prucalopride (Resolor®) in healthy subjects:: Results from a randomized, double-blind, placebo-controlled, cross-over trial
    Boyce, Malcolm J.
    Carey, William
    Mannaert, Erik J.
    Mertens, Annemie
    Ausma, Jannie
    GASTROENTEROLOGY, 2008, 134 (04) : A551 - A551
  • [34] A randomised, double blind cross-over study of serial MRCP following morphine-neostigmine and secretin provocation in healthy volunteers
    Chowdhury, A. H.
    Humes, D. J.
    Pritchard, S.
    Simpson, J.
    Lobo, D. N.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : 33 - 33
  • [35] Effects of Neurapas® balance on sleep EEG, cognitive performance and mood:: A double blind randomised cross-over study in healthy volunteers
    Giesler, M.
    Thum, A.
    Haag, A.
    Wartenberg-Demand, A.
    McGregor, G. P.
    Krieg, J. C.
    Kundermann, B.
    Hemmeter, U.
    PLANTA MEDICA, 2007, 73 (09) : 979 - 979
  • [36] Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
    Lisa M. Pitchford
    Patricia M. Driver
    John C. Fuller
    Wendell S. Akers
    Naji N. Abumrad
    Venkataraman Amarnath
    Ginger L. Milne
    Sheau-Chiann Chen
    Fei Ye
    L. Jackson Roberts
    M. Benjamin Shoemaker
    John A. Oates
    John A. Rathmacher
    Olivier Boutaud
    BMC Pharmacology and Toxicology, 21
  • [37] Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
    Pitchford, Lisa M.
    Driver, Patricia M.
    Fuller, John C., Jr.
    Akers, Wendell S.
    Abumrad, Naji N.
    Amarnath, Venkataraman
    Milne, Ginger L.
    Chen, Sheau-Chiann
    Ye, Fei
    Roberts, L. Jackson, II
    Shoemaker, M. Benjamin
    Oates, John A.
    Rathmacher, John A.
    Boutaud, Olivier
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
  • [38] Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
    Glund, Stephan
    Stangier, Joachim
    Schmohl, Michael
    Gansser, Dietmar
    Norris, Stephen
    van Ryn, Joanne
    Lang, Benjamin
    Ramael, Steven
    Moschetti, Viktoria
    Gruenenfelder, Fredrik
    Reilly, Paul
    Kreuzer, Joerg
    LANCET, 2015, 386 (9994): : 680 - 690
  • [39] GALLOPAMIL AND DILTIAZEM - A DOUBLE-BLIND, RANDOMIZED, CROSS-OVER TRIAL IN EFFORT ISCHEMIA
    MARRACCINI, P
    ORSINI, E
    BRUNELLI, C
    NASSI, G
    GHIGLIOTTI, G
    IANNETTI, M
    CAPONNETTO, S
    LABBATE, A
    EUROPEAN HEART JOURNAL, 1992, 13 (03) : 404 - 410
  • [40] TIPI - A POPULAR ANALGESIC TEA - A DOUBLE-BLIND CROSS-OVER TRIAL IN OSTEOARTHRITIS
    FERRAZ, MB
    PEREIRA, RB
    IWATA, NM
    ATRA, E
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1991, 9 (02) : 205 - 206
12345